Free Trial
→ ZENA Surges: 558% Revenue Growth Fuels Breakout Small-Cap Narrative! (From Equiscreen) (Ad)tc pixel Free CTXR Stock Alerts

Citius Pharmaceuticals (CTXR) Stock Chart & Stock Price History

Citius Pharmaceuticals logo
$0.53 -0.17 (-24.76%)
Closing price 04:00 PM Eastern
Extended Trading
$0.54 +0.01 (+2.28%)
As of 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Citius Pharmaceuticals Stock Price Performance

The Citius Pharmaceuticals (CTXR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 37.88%, with a year-to-date return of -32.18%. In the past month, the stock has decreased 38.60%, reflecting recent market activity.

As of the latest close, Citius Pharmaceuticals traded at $0.70 with a market cap of $15.68 million and volume of 516,793 shares. Five years ago, the stock traded at a split-adjusted price of $53.50, representing a 99.01% decrease over that period. At the time, it had a market cap of $289.91 million and a volume of 206,079 shares.

Receive CTXR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Citius Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-18.92%
1 Month
Performance
-38.60%
3 Month
Performance
-26.51%
Year-To-Date
Performance
-32.18%
1 Year
Performance
-37.88%
5 Year
Performance
-99.01%

CTXR Stock Chart for Monday, May, 18, 2026

CTXR Chart by TradingView

Citius Pharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/15/2026$0.72$0.70
-2.72%		$0.74$0.69516,793 shs$15.68 million
05/14/2026$0.65$0.72
+10.77%		$0.75$0.671.54 million shs$16.11 million
05/13/2026$0.61$0.65
+6.04%		$0.67$0.60682,575 shs$14.55 million
05/12/2026$0.64$0.61
-4.01%		$0.64$0.60704,381 shs$13.72 million
05/11/2026$0.64$0.64
-0.22%		$0.66$0.62674,230 shs$14.29 million
05/08/2026$0.65$0.64
-2.16%		$0.66$0.62823,120 shs$14.64 million
05/07/2026$0.67$0.65
-1.85%		$0.67$0.64630,125 shs$14.64 million
05/06/2026$0.69$0.67
-3.00%		$0.71$0.67691,591 shs$14.91 million
05/05/2026N/A$0.69$0.72$0.68507,596 shs$15.37 million
04/30/2026$0.60$0.70
+16.96%		$0.70$0.631.47 million shs$15.57 million
04/29/2026$0.65$0.60
-8.46%		$0.67$0.571.42 million shs$13.32 million
04/28/2026$0.69$0.65
-5.92%		$0.70$0.631.07 million shs$14.55 million
04/27/2026$0.77$0.69
-10.26%		$0.75$0.662.06 million shs$15.47 million
04/24/2026$0.93$0.77
-17.47%		$0.79$0.693.03 million shs$17.23 million
04/23/2026$0.86$0.93
+8.50%		$1.03$0.883.25 million shs$20.88 million
04/22/2026$0.84$0.86
+1.78%		$0.89$0.84163,544 shs$19.25 million
04/21/2026$0.87$0.84
-3.35%		$0.90$0.83323,812 shs$18.91 million
04/20/2026$0.86$0.87
+1.85%		$0.90$0.83370,541 shs$19.57 million
04/17/2026$0.86$0.86
+0.39%		$0.92$0.85437,010 shs$19.21 million
Related Companies

This page (NASDAQ:CTXR) was last updated on 5/18/2026 by MarketBeat.com Staff.
From Our Partners
Peptide Company Lands Exclusive MMA Wellness Partnership
The Precision Peptide Company (OTCQB: PNGAF) just signed an exclusive partnership with a NYSE-listed MMA media...
The Tomorrow Investor | Sponsoredtc pixel
ZENA Surges: 558% Revenue Growth Fuels Breakout Small-Cap Narrative!
ZenaTech (NASDAQ: ZENA) reported $12.9 million in full-year 2025 revenue, representing 558% year-over-year gro...
Equiscreen | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Musk’s warning just revealed a $1T opportunity
Elon Musk recently warned that AI could force governments to introduce universal income. Mode Mobile isn't wai...
Mode Mobile | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
Your $29.97 book is free today
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel